Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720

被引:384
|
作者
Allende, ML
Sasaki, T
Kawai, H
Olivera, A
Mi, YD
van Echten-Deckert, G
Hajdu, R
Rosenbach, M
Keohane, CA
Mandala, S
Spiegel, S
Proia, RL
机构
[1] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA
[2] NIAMSD, NIH, Bethesda, MD 20892 USA
[3] Univ Bonn, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany
[4] Virginia Commonwealth Univ, Dept Biochem, Sch Med, Richmond, VA 23298 USA
[5] Merck & Co Inc, Res Labs, Dept Immunol & Rheumatol, Rahway, NJ 07065 USA
关键词
D O I
10.1074/jbc.M406512200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sphingosine-1-phosphate (S1P), a lipid signaling molecule that regulates many cellular functions, is synthesized from sphingosine and ATP by the action of sphingosine kinase. Two such kinases have been identified, SPHK1 and SPHK2. To begin to investigate the physiological functions of sphingosine kinase and S1P signaling, we generated mice deficient in SPHK1. Sphk1 null mice were viable, fertile, and without any obvious abnormalities. Total SPHK activity in most Sphk1-/- tissues was substantially, but not completely, reduced indicating the presence of multiple sphingosine kinases. S1P levels in most tissues from the Sphk1 -/- mice were not markedly decreased. In serum, however, there was a significant decrease in the S1P level. Although S1P signaling regulates lymphocyte trafficking, lymphocyte distribution was unaffected in lymphoid organs of Sphk1 -/- mice. The immunosuppressant FTY720 was phosphorylated and elicited lymphopenia in the Sphk1 null mice showing that SPHK1 is not required for the functional activation of this sphingosine analogue prodrug. The results with these Sphk1 null mice reveal that some key physiologic processes that require S1P receptor signaling, such as vascular development and proper lymphocyte distribution, can occur in the absence of SPHK1.
引用
收藏
页码:52487 / 52492
页数:6
相关论文
共 50 条
  • [21] IMMUNOSUPPRESSIVE DRUG FTY720 SENSITIZES PROSTATE CANCER CELLS TO RADIOTHERAPY BY INHIBITION OF SPHINGOSINE KINASE-1
    Pshezhetskiy, Dmitry
    Boehler, Torsten
    Doumerc, Nicolas
    Golzio, Muriel
    Tessie, Justin
    Brinkmann, Volker
    Malavaud, Bernard
    Waxman, Jonathan
    Cuvillier, Olivier
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3453 - 3453
  • [22] FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice
    Nofer, Jerzy-Roch
    Bot, Martine
    Brodde, Martin
    Taylor, Paul J.
    Salm, Paul
    Brinkmann, Volker
    van Berkel, Theo
    Assmann, Gerd
    Biessen, Erik A. L.
    CIRCULATION, 2007, 115 (04) : 501 - 508
  • [23] Systemic Treatment with the Sphingosine-1-Phosphate Analog FTY720 Does Not Improve Fracture Healing in Mice
    Heilmann, Aline
    Schinke, Thorsten
    Bindl, Ronny
    Wehner, Tim
    Rapp, Anna
    Haffner-Luntzer, Melanie
    Liedert, Astrid
    Amling, Michael
    Ignatius, Anita
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2013, 31 (11) : 1845 - 1850
  • [24] Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues
    Don, Anthony S.
    Martinez-Lamenca, Carolina
    Webb, William R.
    Proia, Richard L.
    Roberts, Ed
    Rosen, Hugh
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (21) : 15833 - 15842
  • [25] FTY720 (S)-Phosphonate Preserves Sphingosine 1-Phosphate Receptor 1 Expression and Exhibits Superior Barrier Protection to FTY720 in Acute Lung Injury
    Wang, Lichun
    Sammani, Saad
    Moreno-Vinasco, Liliana
    Letsiou, Eleftheria
    Wang, Ting
    Camp, Sara M.
    Bittman, Robert
    Garcia, Joe G. N.
    Dudek, Steven M.
    CRITICAL CARE MEDICINE, 2014, 42 (03) : E189 - E199
  • [26] The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity
    Bandhuvula, P
    Tam, YY
    Oskouian, B
    Lucas, A
    Saba, JD
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2006, 79 (1-2) : 160 - 160
  • [27] Characterization of the Anticoagulant and Antithrombotic Properties of the Sphingosine 1-Phosphate Mimetic FTY720
    Zhao, Zhen
    Wang, Ruixue
    Huo, Zhijun
    Li, Chunlei
    Wang, Zhiyong
    ACTA HAEMATOLOGICA, 2017, 137 (01) : 1 - 6
  • [28] FTY720 Story: Discovery of the First SPhingosine 1-Phosphate Receptor Modulator
    Adachi, Kunitomo
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 2011, 69 (08) : 904 - 912
  • [29] Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720
    Kihara, Akio
    Igarashi, Yasuyuki
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2008, 1781 (09): : 496 - 502